Detalhe da pesquisa
1.
Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
Nat Genet
; 53(6): 881-894, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972779
2.
Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model.
Nat Genet
; 52(2): 219-230, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32025000
3.
Generation of Genetically Engineered Mouse Lung Organoid Models for Squamous Cell Lung Cancers Allows for the Study of Combinatorial Immunotherapy.
Clin Cancer Res
; 26(13): 3431-3442, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209571
4.
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Nat Med
; 24(7): 968-977, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29808010
5.
CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.
Nat Commun
; 8: 13897, 2017 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28059068
6.
Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
Cancer Immunol Res
; 3(10): 1123-1129, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26081225